Overview

NCI Definition: A chronic myeloproliferative neoplasm characterized by bone marrow fibrosis, proliferation of atypical megakaryocytes and granulocytes in the bone marrow, anemia, splenomegaly, and extramedullary hematopoiesis. (WHO, 2001) [1]

Significant Genes in Primary Myelofibrosis

ABL1 +

AFF1 +

BCR +

DEK +

ELL +

FLT3 +

JAK2 +

KMT2A +

MECOM +

MLF1 +

MLLT1 +

MLLT10 +

MLLT3 +

MLLT4 +

NPM1 +

NUP214 +

PBX1 +

RPN1 +

TCF3 +

TP53 +

Disease Details

Synonyms
Chronic Idiopathic Myelofibrosis, AMM, Idiopathic Bone Marrow Fibrosis, CIMF, Agnogenic Myeloid Metaplasia, Idiopathic Myelofibrosis, Myelosclerosis with Myeloid Metaplasia
Parent(s)
Myeloproliferative Neoplasm
Children
Overt Primary Myelofibrosis and Primary Myelofibrosis, Prefibrotic Stage
OncoTree Name
Primary Myelofibrosis
OncoTree Code
PMF

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/ [2018-08-28]. [2018-09-21].

2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

3. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.